Vaxcyte, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.98 | -$0.98 | -$0.98 |
| Q2 2024 | 1 | -$1.10 | -$1.10 | -$1.10 |
| Q3 2024 | 4 | -$1.84 | -$0.77 | -$1.12 |
| Q1 2025 | 1 | -$1.08 | -$1.08 | -$1.08 |
| Q2 2025 | 1 | -$1.09 | -$1.09 | -$1.09 |
| Q3 2025 | 1 | -$1.12 | -$1.12 | -$1.12 |
| Q4 2025 | 1 | -$1.15 | -$1.15 | -$1.15 |
Vaxcyte, Inc. Earnings Date And Information
Vaxcyte, Inc. last posted its earnings results on Tuesday, November 5th, 2024. The company reported $-0.83 earnings per share for the quarter, topping analysts' consensus estimates of $-0.98 by $0.15. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Vaxcyte, Inc. has generated $-4 earnings per share over the last year ($-4.14 diluted earnings per share) and currently has a price-to-earnings ratio of -21.07. Vaxcyte, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based on prior year's report dates.
Vaxcyte, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/05/2024 | Q3 2024 | -$0.98 | -$0.83 | 0.15 | $0 | $0 |
| 08/06/2024 | Q2 2024 | -$0.98 | -$1.10 | -0.12 | $0 | $0 |
| 05/08/2024 | Q1 2024 | -$1.13 | -$0.85 | 0.28 | $0 | |
| 02/27/2024 | Q4 2023 | -$0.90 | -$1.90 | -1 | $14.45 M | |
| 11/06/2023 | Q3 2023 | -$0.79 | -$0.91 | -0.12 | $0 | |
| 08/08/2023 | Q2 2023 | -$0.67 | -$0.70 | -0.03 | $0 | |
| 05/08/2023 | Q1 2023 | -$0.80 | -$0.56 | 0.24 | $0 | |
| 02/27/2023 | Q4 2022 | -$0.84 | -$1.23 | -0.39 | $0 | |
| 11/07/2022 | Q3 2022 | -$0.80 | -$0.92 | -0.12 | $0 | |
| 08/08/2022 | Q2 2022 | -$0.69 | -$0.81 | -0.12 | $0 | |
| 05/09/2022 | Q1 2022 | -$0.56 | -$0.67 | -0.11 | $0 | |
| 02/28/2022 | Q4 2021 | -$0.46 | -$0.55 | -0.09 | $0 | |
| 11/10/2021 | Q3 2021 | -$0.47 | -$0.51 | -0.04 | $0 | |
| 08/11/2021 | Q2 2021 | -$0.46 | -$0.46 | 0 | $0 | |
| 05/11/2021 | Q1 2021 | -$0.41 | -$0.41 | 0 | $0 | |
| 03/29/2021 | Q4 2020 | -$0.41 | $0 | |||
| 11/12/2020 | Q3 2020 | -$0.42 | -$0.41 | 0.01 | $0 | |
| 08/12/2020 | Q2 2020 | -$1.27 | -$1.72 | -0.45 | $166,667 | $0 |
| 03/30/2020 | Q1 2020 | -$0.58 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.57 | $0 |
Vaxcyte, Inc. Earnings: Frequently Asked Questions
-
When is Vaxcyte, Inc.'s earnings date?
Vaxcyte, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates.
-
Did Vaxcyte, Inc. beat their earnings estimates last quarter?
In the previous quarter, Vaxcyte, Inc. (:PCVX) reported $-0.83 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.98 by $0.15.
-
How can I listen to Vaxcyte, Inc.'s earnings conference call?
The conference call for Vaxcyte, Inc.'s latest earnings report can be listened to online.
-
How can I read Vaxcyte, Inc.'s conference call transcript?
The conference call transcript for Vaxcyte, Inc.'s latest earnings report can be read online.
-
How much profit does Vaxcyte, Inc. generate each year?
Vaxcyte, Inc. (:PCVX) has a recorded net income of $0. Vaxcyte, Inc. has generated $-4.14 earnings per share over the last four quarters.
-
What is Vaxcyte, Inc.'s price-to-earnings ratio?
Vaxcyte, Inc. (:PCVX) has a price-to-earnings ratio of -21.07 and price/earnings-to-growth ratio is -12.54.
